The Business Research Company’s report on the Arrhythmia Monitoring Devices Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
What are the key drivers behind the arrhythmia monitoring devices market’s growth in recent years?
The rising incidence of cardiovascular diseases is expected to drive the arrhythmia monitoring devices market. Cardiovascular disease (CVD) refers to disorders that affect the heart or blood vessels. Arrhythmia monitoring devices are used to monitor irregular heart rates, which is the primary symptom of most cardiovascular diseases. An increase in the incidence of cardiovascular diseases increases the need for arrhythmia monitoring devices. For instance, in August 2022, the American College of Cardiology, a US-based nonprofit medical association published an article according to which the projected rates of cardiovascular risk factors and disease will increase significantly in the United States from the year 2025 to 2060. Factors such as heart failure will increase by 33.4% and ischemic heart disease will increase by 30.7% by the year 2060. Therefore, the rising incidence of cardiovascular diseases will drive the arrhythmia monitoring devices market.
Access Your Free Sample of the Global Arrhythmia Monitoring Devices Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=7437&type=smp
How does the future projection of the arrhythmia monitoring devices market size compare to its historical growth?
The arrhythmia monitoring devices market size has grown strongly in recent years. It will grow from $7.5 billion in 2024 to $8.21 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to aging population, healthcare infrastructure growth, rise in personalized medicine, rise in home healthcare, increased funding.
The arrhythmia monitoring devices market size is expected to see rapid growth in the next few years. It will grow to $12.05 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to rising cardiovascular diseases, telemedicine growth, regulatory approvals, rise in remote patient monitoring, economic growth. Major trends in the forecast period include wearable technology advancements, use of artificial intelligence and machine learning, patient-centric solutions, iot integration, preventive healthcare and health tracking.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=7437&type=smp
Which key players are shaping the future of the arrhythmia monitoring devices market?
Major companies operating in the arrhythmia monitoring devices market include Abbott Laboratories, Medtronic plc, Biotronik Inc., Hill-Rom Services Inc., iRhythm Technologies Inc., GE HealthCare Technologies Inc., Koninklijke Philips NV, ACS Diagnostics Inc., AliveCor Inc., Medi-Lynx Cardiac Monitoring LLC, Welch Allyn Inc., Spacelabs Healthcare Inc., Fukuda Denshi Co. Ltd., Applied Cardiac Systems Inc., BIOTRONIK SE & Co. KG, Hill-Rom Holdings Inc., Nihon Kohden Corporation, CardioNet LLC, Bardy Diagnostics Inc., BioTelemetry Inc., Boston Scientific Corporation, CardioComm Solutions Inc., Cardiac Insight Inc., Cardiac Science Corporation, Johnson & Johnson, Preventice Solutions Inc., Qardio Inc., ZOLL Medical Corporation, Stryker Corporation, Drägerwerk AG & Co. KGaA, Mindray Medical International Limited, Cardinal Health Inc., Physio-Control Corporation
What trends will propel the growth and evolution of the arrhythmia monitoring devices market?
Technological advancements are a key trend in the arrhythmia monitoring devices market. Major companies operating in the arrhythmia monitoring devices market are integrating novel technologies such as AI, detection technologies, and others to increase accuracy and manage data efficiently. For instance, in September 2024, iRhythm Technologies, a US-based digital healthcare company, announced the Japanese Regulatory Approval for the Zio ECG Monitoring System. The Zio system marks a major leap forward in cardiac arrhythmia diagnostics compared to traditional Holter monitoring, offering superior clinical accuracy to assist doctors in making precise diagnoses from the start. iRhythm’s deep learning technology can accurately classify a wide range of distinct arrhythmias, achieving diagnostic performance on par with that of cardiologists. In clinical practice, this service has the potential to reduce the frequency of misdiagnosed computerized ECG interpretations and enhance overall clinical efficiency.
Which regions are expected to become dominant players in the arrhythmia monitoring devices market?
North America was the largest region in the arrhythmia monitoring devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arrhythmia monitoring devices market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/arrhythmia-monitoring-devices-global-market-report
What are the emerging key segments in the arrhythmia monitoring devices market, and how are they evolving?
The arrhythmia monitoring devices market covered in this report is segmented –
1) By Type: ECG, Implantable Monitors, Holter Monitors, Mobile Cardiac Telemetry
2) By Application: Bradycardia, Tachycardia, Atrial Fibrillation, Ventricular Fibrillation, Premature Contraction, Other Applications
3) By End-User: Hospitals And Diagnostic Centers, Ambulatory Centers, Other End Users
Subsegments:
1) By ECG (Electrocardiogram): Resting ECG Machines, Stress ECG Machines, 12-Lead ECG Systems
2) By Implantable Monitors: Implantable Loop Recorders (ILRs), Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
3) By Holter Monitors: 24-Hour Holter Monitors, 48-Hour Holter Monitors, 7-Day Holter Monitors
4) By Mobile Cardiac Telemetry: Wireless Telemetry Devices, Smartphone-Integrated Telemetry Systems
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7437
What defines the structure and scope of the arrhythmia monitoring devices market?
Arrhythmia monitoring devices are equipment that determines the type and cause of abnormal heart rhythms. The arrhythmia monitoring devices are used to track and monitor irregular heart rhythms. Arrhythmia is a heart condition that affects the pace or rhythm of the heartbeat.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
